Nathan Cope

Nathan Cope has a diverse work experience. Nathan started their career as a Research Scientist at Novartis in 2006, before moving on to work as a Scientist at UCB Pharma in 2007. In the same year, they also began working as a Scientist at Babraham Bioscience Technologies Ltd, where they obtained their Ph.D. in Molecular Biology from the University of Cambridge. Nathan then transitioned into consulting, working as a Consultant at PA Consulting Group from 2011 to 2013, and later as a Principal Consultant from 2013 to 2015. Following their consulting roles, they joined Otsuka Pharmaceutical Companies Europe, starting as the European Market Access and Public Affairs from 2015 to 2016. Nathan then took on the role of Digital Health Director from 2016 to 2019, followed by Chief of Staff from 2019 to 2021. Currently, they serve as the Chief Operating Officer at Otsuka Pharmaceutical Companies Europe. In addition to their other roles, Nathan also became a Non Executive Board Member at The McPin Foundation in 2018.

Nathan Cope's education history is as follows:

From 2022 to 2023, Nathan attended INSEAD and completed the Global Leadership Programme. The field of study for this program is not specified.

In 2021 to 2022, Nathan enrolled at the Quantic School of Business and Technology, where they obtained an Executive MBA. No specific field of study is mentioned.

In 2018 to 2019, Nathan participated in the Executive Education Leadership Programme at Hult Ashridge. The program details do not provide a specific field of study.

From 2007 to 2011, Nathan pursued a Ph.D. at the University of Cambridge, specializing in Molecular Biology.

In the period of 2003 to 2007, Nathan attended King's College London and obtained a Bachelor of Science (BSc) degree in Pharmacology & Molecular Genomics.

Additionally, Nathan has obtained certification in Certified Management Consultant (CMC) from the Institute of Consulting in January 2015. In October 2012, they received the PRINCE2 certification from APMG-International.